(Q33464247)

27 July 2017

title

Bleeding and intravascular clotting in malignancy: a review (English)

1 reference

history and philosophy of science

27 July 2017

main subject

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1974.TB14459.X

30 January 2023

author name string

Goodnight SH Jr

1

1 reference

27 July 2017

S. H. Goodnight

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4522874

30 January 2023

language of work or name

English

0 references

publication date

1 January 1974

1 reference

full work available at URL

27 July 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1749-6632.1974.tb14459.x

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1974.TB14459.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1749-6632.1974.tb14459.x/fullpdf

30 January 2023

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1974.TB14459.X

Annals of the New York Academy of Sciences

30 January 2023

published in

1 reference

27 July 2017

volume

230

1 reference

27 July 2017

page(s)

271-288

1 reference

Intravascular coagulation in acute stem cell leukemia successfully treated with heparin

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1974.TB14459.X

Coagulant activity of leukocytes. Tissue factor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1974.TB14459.X

Hypofibrinogenaemia without increased fibrinolysis in leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1974.TB14459.X

Heparin treatment for the hemorrhagic diathesis of acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1974.TB14459.X

Acute promyelocytic leukemia with disseminated intravascular coagulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1974.TB14459.X

EXCESSIVE CONSUMPTION OF BLOOD COAGULATION COMPONENTS AS CAUSE OF HEMORRHAGIC DIATHESIS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1974.TB14459.X

Defibrination syndrome associated with bronchial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1974.TB14459.X

Clotting factor assays on plasma from patients receiving intramuscular of subcutaneous heparin

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1974.TB14459.X

The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies

30 January 2023

2

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1974.TB14459.X

Disappearance of fibrinogen-131-I after endotoxin: effects of a first and second injection

30 January 2023

3

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1974.TB14459.X

Systemic Hemostatic Failure in the Severely Injured Patient

30 January 2023

4

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1974.TB14459.X

Factor V anticoagulants: clinical, biochemical, and immunological observations

30 January 2023

7

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1974.TB14459.X

The Plasma Protamine Paracoagulation Test: Clinical and Laboratory Evaluation

30 January 2023

10

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1974.TB14459.X

The association of fatal intracranial hemorrhage and blastic crisis in patients with acute leukemia.

30 January 2023

11

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1974.TB14459.X

Activated coagulation factors: in-vivo and in-vitro studies

30 January 2023

13

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1974.TB14459.X

Thromboplastic activity of leukemic white cells

30 January 2023

16

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1974.TB14459.X

Stimulation of human leukocyte thromboplastic activity by endotoxin.

30 January 2023

18

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1974.TB14459.X

The Procoagulant Activity of Granulocytes

30 January 2023

20

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1974.TB14459.X

Microangiopathic haemolytic anaemia and mucin-forming adenocarcinoma

30 January 2023

28

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1974.TB14459.X

Glomerular capillary thrombosis and acute renal failure after epsilon-amino caproic acid therapy

30 January 2023

29

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1974.TB14459.X

THE SYMPTOMATIC EFFECT OF ANTICOAGULANT THERAPY IN DEFIBRINATION SYNDROME ASSOCIATED WITH DEMONSTRABLE FIBRIN IN PLASMA: A CASE REPORT

30 January 2023

30

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1974.TB14459.X

Acute hemorrhagic syndrome with hypofibrinogenemia in metastatic cancer

30 January 2023

34

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1974.TB14459.X

30 January 2023

Cryofibrinogenemia

35

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1974.TB14459.X

Acute promyelocytic leukaemia: a report of five cases with a comment on the diagnostic significance of serum vitamin B 12 determination.

30 January 2023

37

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1974.TB14459.X

Intravascular coagulation in promyelocytic leukemia: a case study including ultrastructure

30 January 2023

39

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1974.TB14459.X

Acute promyelocytic leukemia. A report of 3 autopsied cases

30 January 2023

44

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1974.TB14459.X

A CYTOLOGICAL AND HISTOLOGICAL STUDY OF ACUTE PREMYELOCYTIC LEUKAEMIA.

30 January 2023

45

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1974.TB14459.X

Antifibrinolytic activity and metabolism of 6-aminocaproic acid in man

30 January 2023

47

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1974.TB14459.X

Acute Promyelocytc Leukemia

30 January 2023

48

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1974.TB14459.X

Disseminated intravascular coagulation--a complication of chemotherapy in acute myelomonocytic leukemia

30 January 2023

49

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1974.TB14459.X

Hypofibrinogenaemia in acute leukaemia with extensive fibrinous pericarditis

30 January 2023

51

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1974.TB14459.X

Fibrinogenopenia and fibrinolysis in acute myelogenous leukemia

30 January 2023

53

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1974.TB14459.X

Hypofibrinogenaemia in metastatic carcinoma of the prostate: suppression of systemic fibrinolysis by heparin

30 January 2023

55

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1974.TB14459.X

Manifestation and management of hypofibrinogenemia and firinolysis in patients with carcinoma of the prostate

30 January 2023

56

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1974.TB14459.X

Coexistent hypercoagulability and acute hypofibrinogenemia in a patient with prostatic carcinoma

30 January 2023

57

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1974.TB14459.X

Dangerous bleeding associated with carcinoma of prostate.

30 January 2023

58

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1974.TB14459.X

Circulating fibrinolysin in a case of prostatic carcinoma with bony metastases

30 January 2023

59

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1974.TB14459.X

Spontaneous afibrinogenemia in cancer of prostate; report of two cases

30 January 2023

60

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1974.TB14459.X

Hemorrhagic diathesis in patients with carcinoma of prostate

30 January 2023

61

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1974.TB14459.X

The significance of fibrinolysis occurring in patients with metastatic cancer of the prostate

30 January 2023

63

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1974.TB14459.X

Fibrinolysis in metastatic cancer of the prostate

30 January 2023

64

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1974.TB14459.X

ACUTE FATAL FIBRINOLYSIS WITH GASTRIC CARCINOMA

30 January 2023

69

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1974.TB14459.X

Carcinoma of the body of the pancreas with fibrin thrombosis and fibrinogenopenia

30 January 2023

70

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1974.TB14459.X

Acquired fibrinogen deficiency associated with carcinoma of the bronchus

30 January 2023

73

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1974.TB14459.X

Three cases of disseminated intravascular coagulation

30 January 2023

75

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1974.TB14459.X

Coagulation defects and metastatic neuroblastoma

30 January 2023

76

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1974.TB14459.X

Hypofibrinogenemia without fibrinolysis associated with a lymphoma and controlled after treatment with cortisone and nitrogen mustard

30 January 2023

77

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1974.TB14459.X

Microangiopathic haemolytic anaemia associated with consumption coagulopathy in a patient with disseminated carcinoma

30 January 2023

78

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1974.TB14459.X

30 January 2023

Pharmacological Reviews

80

22

97

Mustard J. F.

1970

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1974.TB14459.X

30 January 2023

Identifiers

1 reference

27 July 2017

1 reference